AI Verdict
NBY has stronger fundamentals based on our AI analysis.
NBY vs NAUT Fundamental Comparison
| Metric | NBY | NAUT |
|---|---|---|
| Revenue | $521,000.0 | N/A |
| Net Income | $-22.1M | $-59.0M |
| Net Margin | -4,249.7% | N/A |
| ROE | N/A | -37.6% |
| ROA | -245.1% | -30.9% |
| Current Ratio | 7.60x | 13.33x |
| Debt/Equity | N/A | 0.00x |
| EPS | $0.76 | $-0.47 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NBY vs NAUT: Frequently Asked Questions
Is NBY or NAUT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NBY has stronger fundamentals. NBY is rated STRONG SELL (95% confidence) while NAUT is rated STRONG SELL (88% confidence). This is not investment advice.
How does NBY compare to NAUT fundamentally?
NovaBay Pharmaceuticals, Inc. has ROE of N/A vs Nautilus Biotechnology, Inc.'s -37.6%. Net margins are -4,249.7% vs N/A respectively.
Which stock pays higher dividends, NBY or NAUT?
NBY has a dividend yield of N/A or no dividend while NAUT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NBY or NAUT for long term?
For long-term investing, consider that NBY has STRONG SELL rating with 95% confidence, while NAUT has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NBY vs NAUT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NBY vs NAUT, the AI consensus favors NBY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.